SARS-CoV-2 Infection
6 competing products in clinical development for SARS-CoV-2 Infection.
Pipeline by Phase
Phase 13
Phase 2/31
Phase 32
All Products (6)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| S-217622 + Placebo | Shionogi | Phase 3 | Completed | 40 |
| S-217622 + Placebo | Shionogi | Phase 3 | Completed | 40 |
| CT-P59 + CT-P59 + Placebo + CT-P59 + Placebo | Celltrion | Phase 2/3 | Completed | 38 |
| CT-P59 | Celltrion | Phase 1 | Completed | 29 |
| CT-P63 + Placebo | Celltrion | Phase 1 | Completed | 29 |
| CT-P59 + Placebo | Celltrion | Phase 1 | Completed | 29 |